Last updated on August 2019

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma


Brief description of study

The purpose of the study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug called NKTR-214, when combined with nivolumab versus nivolumab given alone in participants with previously untreated melanoma skin cancer that is either unable to be surgically removed or has spread

Clinical Study Identifier: NCT03635983

Find a site near you

Start Over

Local Institution

Los Angeles, CA United States
  Connect »

Local Institution

Aurora, CO United States
  Connect »

Local Institution

New Haven, CT United States
  Connect »

Local Institution

Louisville, KY United States
  Connect »

Local Institution

Boston, MA United States
  Connect »

Local Institution

Minneapolis, MN United States
  Connect »

Local Institution

Buffalo, NY United States
  Connect »

Local Institution

New York, NY United States
  Connect »

Local Institution

Cleveland, OH United States
  Connect »

Local Institution

Autonoma, Argentina
  Connect »

Local Institution

North Sydney, Australia
  Connect »

Local Institution

Melbourne, Australia
  Connect »

Local Institution

Nedlands, Australia
  Connect »

Local Institution

Belo Horizonte, Brazil
  Connect »

Local Institution

Porto Alegre, Brazil
  Connect »

Local Institution

Edmonton, AB Canada
  Connect »

Local Institution

Abbotsford, BC Canada
  Connect »

Local Institution

St. John's, NL Canada
  Connect »

Local Institution

Hamilton, ON Canada
  Connect »

Local Institution

Kitchener, ON Canada
  Connect »

Local Institution

Hradec Kralove, Czechia
  Connect »

Local Institution

Moscow, Russian Federation
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Edinburgh, United Kingdom
  Connect »

Local Institution

Belfast, United Kingdom
  Connect »

Local Institution

Cambridge, United Kingdom
  Connect »

Local Institution

Cottingham, United Kingdom
  Connect »

Local Institution

Manchester, United Kingdom
  Connect »

Local Institution

Southampton, United Kingdom
  Connect »

Local Institution

Wirral, United Kingdom
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Leiden, Netherlands
  Connect »

Local Institution

Nijmegen, Netherlands
  Connect »

Local Institution

Tauton, United Kingdom
  Connect »

Local Institution

Greenslopes, Australia
  Connect »

Local Institution

Woolloongabba, Australia
  Connect »

Local Institution

Christchurch, New Zealand
  Connect »

Local Institution

Wellington, New Zealand
  Connect »

Local Institution

Sutton., United Kingdom
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Local Institution

Coffs Harbour, Australia
  Connect »

Local Institution

Cluj-Napoca, Romania
  Connect »

Local Institution

Stanford, CA United States
  Connect »

Institut Claudius Regaud

Toulouse Cedex 9, France
  Connect »

Local Institution

Goettingen, Germany
  Connect »

Local Institution

Heidelberg, Germany
  Connect »

Local Institution

Regensburg, Germany
  Connect »

Local Institution

Utrecht, Netherlands
  Connect »

Local Institution

Lausanne, Switzerland
  Connect »

Local Institution

Zurich, Switzerland
  Connect »

Clinica Adventista Belgrano

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Local Institution

Utrecht, United Kingdom
  Connect »